When: $84 (July crash low / lower Bollinger band)

Then: Exit position

When: Sustained close below $69.50 (200-day SMA)

Then: Full exit

HOLD with strict risk controls—do not add below 108-110, respect stop at 84, reduce on close below 96.07 with RSI under 40 and deteriorating MACD

• Forward P/E of 49x is fragile given 4 consecutive process node delays/misses and negative $2.09 TTM EPS
• Stock fell from 142 to 81 in three weeks, with 8.72 dollars below the declining 50-day SMA at 109.67
• MACD negative at minus 2.74, RSI neutral at 49.98, ATR elevated at 7.39, beta at 2.24
• Gross margin compressed from 42.6% in 2022 to 34.8% in 2025
• Dividend cut from $6 billion in 2022 to zero in 2025—not strategic capital allocation but survival necessity
• 15% dilution in twelve months; stock fell 3.7% on equity offering announcement
• CEO insider purchase of $12 million contextualized as standard executive compensation alignment, not conviction
• 18A node delayed multiple times; will compete against TSMC's N2 already in volume production
• 86% Polymarket probability of no Fed rate cuts in 2026 compresses growth-stock multiples
• Polymarket pricing an 86% probability of no Fed rate cuts in 2026 creates headwind for 49x multiple
• Entry trigger at 108-110 is only responsible level to add—below declining 50-day SMA means buying into falling intermediate trend
• Decline from 127 to 81 with ATR of 7.39 and beta of 2.24 warrants smaller position sizing than model portfolio average

→ vs aggressive: 49x forward P/E is not rational—it is fragile, with four-year track record of $30 billion FCF destruction and negative EPS

→ vs aggressive: Technical damage IS the fundamental inflection reflected in price; the 10-day EMA at 98.04 is a bounce within a damaged intermediate trend, not confirmation

→ vs aggressive: $12 million CEO purchase is a documented signaling device used at issuance prices, not founder-level conviction

→ vs aggressive: Single historical analog (2013 equity event followed by 7x rally) is cherry-picked from different era; 2004 and 2013 Intel events produced different outcomes

→ vs aggressive: Gross margin compression from 42.6% to 34.8% is not a moat—it is loss of pricing power against competitors with better unit economics

→ vs aggressive: Dividend suspension is not bold capital allocation—it is inability to afford the payout after exhausting other options

→ vs aggressive: Macro is a headwind, not neutral—86% probability of no Fed cuts in 2026 compresses growth-stock multiples

→ vs aggressive: Entry at 108-110 is not too patient; it is the only responsible level given the declining 50-day SMA

HOLD

• Maintain existing position with no forced action; position sizing should be materially smaller given 2.24 beta and $7.39 ATR
• Entry trigger at $108-110 with technical confirmation (RSI pushing through 50, MACD crossing bullish) is appropriate and not too patient
• Pre-commit to stop at $84 and early warning level at $96.07 close with RSI below 40
• Asymmetric risk is roughly balanced - one good quarter versus four-year execution track record and widening competitive landscape
• Macro headwind (86% probability of no Fed cuts in 2026) is already priced in and not a reason to avoid the position entirely
• Conservative position management (waiting for $108-110 confirmation) is appropriately disciplined, not market-timing perfectionism
• Beta of 2.24 and ATR of $7.39 mean two-sigma daily moves regularly exceed 10 percent
• Current price at $101 reflects market skepticism about whether Q2 inflection sustains

→ vs aggressive: Survivorship bias undermines Tesla and Nvidia comparisons - for every success story, dozens of identical-looking situations failed; treating every dip below $98 as an add opportunity is aggression dressed as analysis, not conviction

→ vs aggressive: Dismissal of mean-reversion is incorrect - market already priced in Q2 2026 at $127-$142; current $101 price reflects significant doubt about whether one quarter changes the four-year picture

→ vs conservative: Dismissing CEO's $12 million personal buy as 'well-documented signaling device' is too cynical - most CEOs don't put personal capital into deals they're raising, and this signals conviction level that matters for institutional positioning

→ vs conservative: Treating historical analog (Intel's last equity raise preceded seven-fold move) as worthless overcorrects - while single analogs aren't theses, they're one piece of evidence combined with operational inflection, insider buying, analyst endorsements, and funded roadmap

→ vs conservative: Position management framing is counterproductive - waiting for 'clean confirmation' on high-beta names often means buying 15-20% higher or missing moves entirely when catalysts arrive faster than technical setups